These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

467 related articles for article (PubMed ID: 20868676)

  • 1. Systemic cannabinoids produce CB₁-mediated antinociception by activation of descending serotonergic pathways that act upon spinal 5-HT(7) and 5-HT(2A) receptors.
    Seyrek M; Kahraman S; Deveci MS; Yesilyurt O; Dogrul A
    Eur J Pharmacol; 2010 Dec; 649(1-3):183-94. PubMed ID: 20868676
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Systemic paracetamol-induced analgesic and antihyperalgesic effects through activation of descending serotonergic pathways involving spinal 5-HT₇ receptors.
    Dogrul A; Seyrek M; Akgul EO; Cayci T; Kahraman S; Bolay H
    Eur J Pharmacol; 2012 Feb; 677(1-3):93-101. PubMed ID: 22206817
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Spinal 5-HT7 receptors play an important role in the antinociceptive and antihyperalgesic effects of tramadol and its metabolite, O-Desmethyltramadol, via activation of descending serotonergic pathways.
    Yanarates O; Dogrul A; Yildirim V; Sahin A; Sizlan A; Seyrek M; Akgül O; Kozak O; Kurt E; Aypar U
    Anesthesiology; 2010 Mar; 112(3):696-710. PubMed ID: 20179508
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Systemic morphine produce antinociception mediated by spinal 5-HT7, but not 5-HT1A and 5-HT2 receptors in the spinal cord.
    Dogrul A; Seyrek M
    Br J Pharmacol; 2006 Nov; 149(5):498-505. PubMed ID: 16921395
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential mediation of descending pain facilitation and inhibition by spinal 5HT-3 and 5HT-7 receptors.
    Dogrul A; Ossipov MH; Porreca F
    Brain Res; 2009 Jul; 1280():52-9. PubMed ID: 19427839
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Involvement of descending serotonergic and noradrenergic pathways in CB1 receptor-mediated antinociception.
    Dogrul A; Seyrek M; Yalcin B; Ulugol A
    Prog Neuropsychopharmacol Biol Psychiatry; 2012 Jul; 38(1):97-105. PubMed ID: 22300745
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Roles of 5-hydroxytryptamine (5-HT) receptor subtypes in the inhibitory effects of 5-HT on C-fiber responses of spinal wide dynamic range neurons in rats.
    Liu FY; Xing GG; Qu XX; Xu IS; Han JS; Wan Y
    J Pharmacol Exp Ther; 2007 Jun; 321(3):1046-53. PubMed ID: 17329553
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antinociceptive effects of central administration of the endogenous cannabinoid receptor type 1 agonist VDPVNFKLLSH-OH [(m)VD-hemopressin(α)], an N-terminally extended hemopressin peptide.
    Han ZL; Fang Q; Wang ZL; Li XH; Li N; Chang XM; Pan JX; Tang HZ; Wang R
    J Pharmacol Exp Ther; 2014 Feb; 348(2):316-23. PubMed ID: 24307201
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 3-[2-cyano-3-(trifluoromethyl)phenoxy]phenyl-4,4,4-trifluoro-1-butanesulfonate (BAY 59-3074): a novel cannabinoid Cb1/Cb2 receptor partial agonist with antihyperalgesic and antiallodynic effects.
    De Vry J; Denzer D; Reissmueller E; Eijckenboom M; Heil M; Meier H; Mauler F
    J Pharmacol Exp Ther; 2004 Aug; 310(2):620-32. PubMed ID: 15140913
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antinociceptive effects of the non-selective cannabinoid receptor agonist CP 55,940 are absent in CB1(-/-) and not CB2(-/-) mice in models of acute and persistent pain.
    Sain NM; Liang A; Kane SA; Urban MO
    Neuropharmacology; 2009 Sep; 57(3):235-41. PubMed ID: 19538975
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lack of cross-tolerance to the antinociceptive effects of systemic and topical cannabinoids in morphine-tolerant mice.
    Yeşilyurt O; Dogrul A
    Neurosci Lett; 2004 Nov; 371(2-3):122-7. PubMed ID: 15519741
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The critical role of spinal 5-HT7 receptors in opioid and non-opioid type stress-induced analgesia.
    Yesilyurt O; Seyrek M; Tasdemir S; Kahraman S; Deveci MS; Karakus E; Halici Z; Dogrul A
    Eur J Pharmacol; 2015 Sep; 762():402-10. PubMed ID: 25917322
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A role for cannabinoid receptors, but not endogenous opioids, in the antinociceptive activity of the CB2-selective agonist, GW405833.
    Whiteside GT; Gottshall SL; Boulet JM; Chaffer SM; Harrison JE; Pearson MS; Turchin PI; Mark L; Garrison AE; Valenzano KJ
    Eur J Pharmacol; 2005 Dec; 528(1-3):65-72. PubMed ID: 16316650
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serotonergic neurotransmission in the dorsal raphe nucleus recruits in situ 5-HT(2A/2C) receptors to modulate the post-ictal antinociception.
    Freitas RL; Bassi GS; de Oliveira AM; Coimbra NC
    Exp Neurol; 2008 Oct; 213(2):410-8. PubMed ID: 18671968
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The synthetic TRH analogue taltirelin exerts modality-specific antinociceptive effects via distinct descending monoaminergic systems.
    Tanabe M; Tokuda Y; Takasu K; Ono K; Honda M; Ono H
    Br J Pharmacol; 2007 Feb; 150(4):403-14. PubMed ID: 17220907
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Involvement of Descending Serotonergic and Noradrenergic Systems and their Spinal Receptor Subtypes in the Antinociceptive Effect of Dipyrone.
    Gencer A; Gunduz O; Ulugol A
    Drug Res (Stuttg); 2015 Dec; 65(12):645-9. PubMed ID: 25647230
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Monoaminergic neurotransmission contributes to cannabinoid-induced activation of the hypothalamic-pituitary-adrenal axis.
    McLaughlin RJ; Hill MN; Gorzalka BB
    Eur J Pharmacol; 2009 Dec; 624(1-3):71-6. PubMed ID: 19818759
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antinociception and inhibition from the periaqueductal gray are mediated in part by spinal 5-hydroxytryptamine(1A) receptors.
    Lin Q; Peng YB; Willis WD
    J Pharmacol Exp Ther; 1996 Mar; 276(3):958-67. PubMed ID: 8786576
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Roles of serotonin receptor subtypes for the antinociception of 5-HT in the spinal cord of rats.
    Jeong CY; Choi JI; Yoon MH
    Eur J Pharmacol; 2004 Oct; 502(3):205-11. PubMed ID: 15476746
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Topical cannabinoid antinociception: synergy with spinal sites.
    Dogrul A; Gul H; Akar A; Yildiz O; Bilgin F; Guzeldemir E
    Pain; 2003 Sep; 105(1-2):11-6. PubMed ID: 14499415
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.